JP2011026234A5 - - Google Patents

Download PDF

Info

Publication number
JP2011026234A5
JP2011026234A5 JP2009172880A JP2009172880A JP2011026234A5 JP 2011026234 A5 JP2011026234 A5 JP 2011026234A5 JP 2009172880 A JP2009172880 A JP 2009172880A JP 2009172880 A JP2009172880 A JP 2009172880A JP 2011026234 A5 JP2011026234 A5 JP 2011026234A5
Authority
JP
Japan
Prior art keywords
pores
wrinkle
makeup
partial
pore
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009172880A
Other languages
Japanese (ja)
Other versions
JP2011026234A (en
JP5562589B2 (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2009172880A priority Critical patent/JP5562589B2/en
Priority claimed from JP2009172880A external-priority patent/JP5562589B2/en
Publication of JP2011026234A publication Critical patent/JP2011026234A/en
Publication of JP2011026234A5 publication Critical patent/JP2011026234A5/ja
Application granted granted Critical
Publication of JP5562589B2 publication Critical patent/JP5562589B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

[製造方法]
(1)成分1〜1を約85℃にて均一に混合、溶解、分散させた後、室温まで冷却し、毛穴、小じわ隠し料(部分用化粧下地)を得た。
[Production method]
(1) Components 1 to 18 were uniformly mixed, dissolved and dispersed at about 85 ° C., and then cooled to room temperature to obtain pores and fine wrinkles (partial makeup base).

表1の結果から明らかなように、本発明に係わる実施例1〜8は比較例と比して、毛穴や小じわ等の皮膚表面の凹凸を目立たなくすることができるとともに、紫外線防止効果を有するという、2つの機能を兼備した毛穴、しわ隠し料(部分用化粧下地)であった。さらに詳しくは、皮膚へのつき、のびが良く、化粧持続性に優れ、長期保存しても変臭、変色、凝集、分離等の変質が生じない良好な安定性を有し、かつ安全性の高い毛穴、しわ隠し料(部分用化粧下地)であった。これに対して比較例1〜では、紫外線防止効果が無いか、毛穴、小じわ隠し効果、使用感及び化粧持続性、安定性試験について不良であった。
As is clear from the results in Table 1, Examples 1 to 8 according to the present invention can make the unevenness of the skin surface such as pores and fine wrinkles inconspicuous and have an ultraviolet ray preventing effect as compared with the comparative example. It was a pore and wrinkle concealing agent (partial makeup base) that had two functions. More specifically, it has good stability on the skin, spreads well, has excellent makeup persistence, does not cause deterioration such as odor, discoloration, aggregation, separation, etc. even after long-term storage, and is safe. High pores, wrinkle concealment (partial makeup base). On the other hand, in Comparative Examples 1-4 , there was no ultraviolet-ray prevention effect or it was unsatisfactory about a pore, a fine wrinkle concealment effect, a feeling of use, makeup sustainability, and a stability test.

JP2009172880A 2009-07-24 2009-07-24 Cosmetic composition Active JP5562589B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009172880A JP5562589B2 (en) 2009-07-24 2009-07-24 Cosmetic composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009172880A JP5562589B2 (en) 2009-07-24 2009-07-24 Cosmetic composition

Publications (3)

Publication Number Publication Date
JP2011026234A JP2011026234A (en) 2011-02-10
JP2011026234A5 true JP2011026234A5 (en) 2012-07-12
JP5562589B2 JP5562589B2 (en) 2014-07-30

Family

ID=43635409

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009172880A Active JP5562589B2 (en) 2009-07-24 2009-07-24 Cosmetic composition

Country Status (1)

Country Link
JP (1) JP5562589B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6545953B2 (en) * 2014-12-22 2019-07-17 ポーラ化成工業株式会社 Emulsion-type external skin preparation
JP7014417B2 (en) 2018-05-17 2022-02-01 住江織物株式会社 Dimmable curtains and fabrics

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19541968C2 (en) * 1995-11-10 2000-01-13 Beiersdorf Ag Stable hydrocarbon-free cosmetic or dermatological oleogels and W / O emulsions
JP4191314B2 (en) * 1999-04-28 2008-12-03 株式会社コーセー Cosmetics
EP1136064A3 (en) * 2000-03-21 2001-10-17 Avon Products, Inc. Method for improving the apperance of skin and topical compositions for practicing the same
JP4495870B2 (en) * 2001-02-19 2010-07-07 花王株式会社 Cosmetics
JP2002322030A (en) * 2001-04-26 2002-11-08 Kose Corp Unevenness-correcting cosmetic
JP2003252742A (en) * 2002-02-28 2003-09-10 Kose Corp Melanocyte dendrite formation inhibitor and skin care preparation containing the same
US20040228821A1 (en) * 2003-05-16 2004-11-18 The Procter & Gamble Company Personal care products comprising active agents in a gel network
EP1602351A1 (en) * 2004-05-24 2005-12-07 The Procter & Gamble Company High coverage cosmetic foundation
US8017136B2 (en) * 2004-05-24 2011-09-13 The Procter & Gamble Company Shiny foundation
TWI354567B (en) * 2005-09-07 2011-12-21 Kao Corp Transparent solid cosmetic powder

Similar Documents

Publication Publication Date Title
JP2006291180A5 (en)
JP2017128738A5 (en)
WO2016014741A3 (en) Treatment compositions
BR112017008761A2 (en) respirator that has corrugated filter structure
CA3010919A1 (en) Treatment compositions
WO2015010078A3 (en) Substituted 6,5-fused bicyclic heteroaryl compounds
BR112014015883A2 (en) Monobenzoate useful as a plasticizer in plastisol compositions
WO2013129889A3 (en) High-content fast dissolving film with masking of bitter taste comprising sildenafil as active ingredient
NZ631429A (en) Porous carbon particles for use in the treatment or prevention of liver disease
WO2016156992A3 (en) Powder compositions for generating cross-linked protein foams and methods of using thereof
JP2015509122A5 (en)
WO2014120936A3 (en) Treatments for depression and other diseases with a low dose agent
WO2018084627A3 (en) Pharmaceutical complex formulation comprising amlodipine, losartan and chlorthalidone
BR112018016307A2 (en) composition and product uses, method of combating odors and composition
WO2014060852A3 (en) Compounds useful in the synthesis of benzamide compounds
WO2015195863A8 (en) Hydrated 2-((4s)-6-(4-chlorophenyl)-1 -methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide
WO2019108021A3 (en) Pharmaceutical composition comprising tofacitinib
JP2011026234A5 (en)
EP3295932A3 (en) Stable odf composition containing hardly soluble therapeutic agent
WO2015126129A3 (en) Resveratrol multimer having selective inhibitory activity for hepatitis c virus genome replication, and use thereof
AU2018332214A8 (en) Modified nucleoside phosphoramidites
WO2015066664A3 (en) Compositions and methods for administration of an enzyme to a subject's airway
JP2009001575A5 (en)
MX2021004332A (en) AZEOTROPE OR AZEOTROPE-LIKE COMPOSITIONS OF TRIFLUOROIODOMETHANE (CF3I) AND 1,1,1,3,3,3–HEXAFLUOROPROPANE (HFC-236fa).
JP2013213023A5 (en)